RNA-seq data analysis of stimulated hepatocellular carcinoma cells treated with epigallocatechin gallate and fisetin reveals target genes and action mechanisms

RNA-seq data analysis of stimulated hepatocellular carcinoma cells treated with epigallocatechin gallate and fisetin reveals target genes and action mechanisms

Hepatocellular carcinoma (HCC) is an essentially incurable inflammation-related cancer. We have previously shown by network analysis of proteomic data that the flavonoids epigallocatechin gallate (EGCG) and fisetin (FIS) efficiently downregulated pro-tumor cytokines released by HCC through inhibitio...

Full description

Bibliographic Details
Main Authors:	Panagiotis C. Agioutantis, Vasilios Kotsikoris, Fragiskos N. Kolisis, Heleni Loutrari
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Computational and Structural Biotechnology Journal
Subjects:	RNA-sequencing Hepatocellular carcinoma Epigallocatechin gallate Fisetin Transcription factors Gene Ontology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2001037019304805

Similar Items

Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives
by: Bimonte S, et al.
Published: (2019-02-01)

Computational Analysis of Transcriptomic and Proteomic Data for Deciphering Molecular Heterogeneity and Drug Responsiveness in Model Human Hepatocellular Carcinoma Cell Lines
by: Panagiotis C. Agioutantis, et al.
Published: (2020-06-01)

Skin Protective Effect of Epigallocatechin Gallate
by: Eunji Kim, et al.
Published: (2018-01-01)

Analysis of naturally occurring 3″-Methyl-epigallocatechin gallate in 71 major tea cultivars grown in China and its processing characteristics
by: Hai-peng Lv, et al.
Published: (2014-03-01)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
by: Hao-Han Yu, et al.
Published: (2017-02-01)

Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes
by: Sang-Nam Kim, et al.
Published: (2017-06-01)

Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
by: Derliz Mereles, et al.
Published: (2011-08-01)

Effect of (−)-Epigallocatechin Gallate to Staphylococcal Enterotoxin A on Toxin Activity
by: Yuko Shimamura, et al.
Published: (2020-04-01)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
by: Ying Zhong, et al.
Published: (2012-01-01)

THE EFFECT OF GREEN TEA EXTRACT - EPIGALLOCATECHIN GALLATE (EGCG) ON PORCINE OVARIAN GRANULOSA CELL
by: Attila Kádasi, et al.
Published: (2014-02-01)

Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallate
by: Lei Chen, et al.
Published: (2007-05-01)

Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro.
by: Francesca eOliviero, et al.
Published: (2013-04-01)

Curcumin and (−)- Epigallocatechin-3-Gallate Protect Murine MIN6 Pancreatic Beta-Cells against Iron Toxicity and Erastin-Induced Ferroptosis
by: Tugba Kose, et al.
Published: (2019-02-01)

Carboplatin and epigallocatechin-3-gallate synergistically induce cytotoxic effects in esophageal cancer cells
by: Fatemeh Taghvaei, et al.
Published: (2021-01-01)

The Effect of Nano-Epigallocatechin-Gallate on Oxidative Stress and Matrix Metalloproteinases in Experimental Diabetes Mellitus
by: Adriana Elena Bulboaca, et al.
Published: (2020-02-01)

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
by: Xin Zhang, et al.
Published: (2016-05-01)

Thiamine in Lipid Systems vs. the Antioxidant Activity of Epigallocatechin Gallate and Caffeine
by: Justyna Piechocka, et al.
Published: (2021-04-01)

Polyphenol (-)-epigallocatechin gallate targeting myocardial reperfusion limits infarct size and improves cardiac function
by: Chan Jin Kim, et al.
Published: (2010-02-01)

Epigallocatechin-3-Gallate Protects Pro-Acinar Epithelia Against Salivary Gland Radiation Injury
by: Erni Sulistiyani, et al.
Published: (2021-03-01)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
by: L. Tang, et al.
Published: (2017-08-01)

The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes
by: Yu-Wen Chu, et al.
Published: (2017-08-01)

Antibacterial and antifungal activities of new acylated derivatives of epigallocatechin gallate
by: Yoshimi eMatsumoto, et al.
Published: (2012-02-01)

Assessment Synergistic Effects of Integrated Therapy with Epigallocatechin-3-Gallate (EGCG) & Arsenic Trioxide and Irradiation on Breast Cancer Cell Line
by: Vahid CHANGIZI, et al.
Published: (2020-07-01)

Preparation of chitosan-Epigallocatechin-3-O-gallate nanoparticles and their inhibitory effect on the growth of breast cancer cells
by: Yingyi Liu, et al.
Published: (2018-07-01)

ANTIOXIDATIVE EFFECT OF EPIGALLOCATECHIN GALLATE AGAINST D-GALACTOSAMINE-INDUCED INJURY IN PRIMARY CULTURE OF RAT HEPATOCYTES
by: Alena Moravcová, et al.
Published: (2014-01-01)

Bioavailability of Epigallocatechin Gallate Administered With Different Nutritional Strategies in Healthy Volunteers
by: Vicente Andreu Fernández, et al.
Published: (2020-05-01)

Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
by: Rui-Qiang Zhao, et al.
Published: (2019-01-01)

Effects of Epigallocatechin Gallate on Tissue Lipid Peroxide Levels in Traumatized Spinal Cord of Rat
by: Ali Reza Khalatbary, et al.
Published: (2010-09-01)

Efficacy of topical hydrogel Epigallocatechin-3-gallate against neutrophil cells in perforated dental pulp
by: Kun Ismiyatin, et al.
Published: (2020-06-01)

Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
by: Jin-Jing Jia, et al.
Published: (2017-11-01)

The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients
by: Jose Luis Platero, et al.
Published: (2021-04-01)

Characterization of Epigallocatechin-Gallate-Grafted Chitosan Nanoparticles and Evaluation of Their Antibacterial and Antioxidant Potential
by: María J. Moreno-Vásquez, et al.
Published: (2021-04-01)

Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer
by: Mehdi Sharifi-Rad, et al.
Published: (2020-01-01)

Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25
by: Lingling Zan, et al.
Published: (2019-01-01)

Neuroprotective effects of epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a histological study
by: Homa Rassouli, et al.
Published: (2009-01-01)

Neuroprotective effects of epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a histological study
by: Homa Rassouli, et al.
Published: (2009-01-01)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
by: Yun-Ju Huang, et al.
Published: (2020-10-01)

The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
by: Bimonte S, et al.
Published: (2020-10-01)

Effect of (−)-Epigallocatechin Gallate on Activation of JAK/STAT Signaling Pathway by Staphylococcal Enterotoxin A
by: Yuko Shimamura, et al.
Published: (2021-08-01)

Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: a preliminary study
by: Sang Kwon Lee, et al.
Published: (2012-10-01)

Cannot write session to /tmp/vufind_sessions/sess_cj38lo1ku2eh0s5gn3iit3f2nf